4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-013481
Director sold 31,902 shares at an average $41.45 ($1,322,217)
From the SEC's structured data for this filing
Trades in this filing
Brenner Malcolm · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-19 | Sale : show line 1 in the form | −11,990 | $41.78 | $500,935 | 988,531 | I |
| 2021-02-22 | Sale : show line 2 in the form | −2,334 | $41.58 | $97,054 | 986,197 | I |
| 2021-02-22 | Sale : show line 3 in the form | −8,779 | $42.80 | $375,746 | 977,418 | I |
| 2021-02-22 | Sale : show line 4 in the form | −310 | $43.38 | $13,446 | 977,108 | I |
| 2021-02-23 | Sale : show line 5 in the form | −2,800 | $38.75 | $108,499 | 974,308 | I |
| 2021-02-23 | Sale : show line 6 in the form | −3,688 | $39.46 | $145,529 | 970,620 | I |
| 2021-02-23 | Sale : show line 7 in the form | −1,801 | $40.40 | $72,769 | 968,819 | I |
| 2021-02-23 | Sale : show line 8 in the form | −200 | $41.19 | $8,238 | 968,619 | I |
| Open-market sales · 31,902 sh · avg $41.45 · $1,322,217 | ||||||
Loading xslF345X03/doc4.xml…